NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637905. A total of 3 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $895,000 | +1.0% | 1,678,800 | +27.9% | 0.00% | -25.0% |
| Q2 2020 | $886,000 | +490.7% | 1,312,800 | +402.6% | 0.00% | +300.0% |
| Q1 2020 | $150,000 | +85.2% | 261,200 | +327.5% | 0.00% | 0.0% |
| Q4 2019 | $81,000 | -45.3% | 61,100 | -17.4% | 0.00% | 0.0% |
| Q3 2019 | $148,000 | -9.2% | 74,000 | +10.4% | 0.00% | 0.0% |
| Q2 2019 | $163,000 | -4.1% | 67,000 | -3.9% | 0.00% | -50.0% |
| Q1 2019 | $170,000 | +16900.0% | 69,700 | +13840.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | -98.7% | 500 | -97.7% | 0.00% | -100.0% |
| Q2 2018 | $76,000 | +40.7% | 21,800 | +103.7% | 0.00% | 0.0% |
| Q1 2018 | $54,000 | -12.9% | 10,700 | +2.9% | 0.00% | – |
| Q4 2017 | $62,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 261,200 | $150,000 | 0.00% |
| SIMPLEX TRADING, LLC | 842 | $48,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |